Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women's and general health, eye health, gastrointestinal diseases, and toxicology worldwide.
Why I'm buying right now:
Price target is from low 165.00 to high 341.00
2019 earnings - 72.92 M -> 2020 earnings -...
Upcoming earning estimate is 9.94, we will see the real earnings tomorrow. Everything else is looking good, so oversold. The gap from November could be filled pretty quickly. Possible LT, PT 278, then 401.